GL1X · GenesisL1 explorer

MolNFT v1 · #60377 · protein

Subsite mapping of the active site of human pancreatic alpha-amylase using substrates, the pharmacological inhibitor acarbose, and an active site variant

3CPU: “Subsite mapping of the active site of human pancreatic alpha-amylase using substrates, the pharmacological…”. X-ray diffraction, 3 ligands (GLC, CA, CL), 3 pockets (best druggability 0.56). MolNFT v1 #60377 on GenesisL1: 3D…

PDB
3CPU
Type
protein
Length
496 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pancreatic alpha-amylase
EC
3.2.1.1
UniProt
P04746
Ligands
GLC, CA, CL
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APancreatic alpha-amylase (EC 3.2.1.1)protein49627% helix, 24% strandP04746

Ligands and binding sites

  • GLC · alpha-D-glucopyranose · sugar · 2 copies · chains A
  • CA · Calcium ion · metal · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12190.560.7827GLC
2700.340.7618empty
3850.330.7421empty

Modifications

Observed in the structure: 5 disulfide, 1 modified (disulfide, cyclization).

Compared structures

  • 3CPU · Subsite mapping of the active site of human pancreatic alpha-amylase using substrates… · the same entry in another collection · chain A against A, TM-score 1.00
  • P04746 · AlphaFold monomer V2.0 prediction for pancreatic alpha-amylase (P04746) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.